Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAN-AIM to PREVENT: CANadian Study, Assessing Inflammatory Markers to PRedict EVents in Nephrology sTudy

NCT01974713 is registered in ClinicalTrials.gov with Institute of Kidney Lifescience Technologies as lead sponsor.

NCT NCT01974713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01974713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAN-AIM to PREVENT: CANadian Study, Assessing Inflammatory Markers to PRedict EVents in Nephrology sTudy
Lead sponsor
Institute of Kidney Lifescience Technologies
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2017
Enrollment
2,530 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease